Select Page

Press Release

Sun Pharma receives DCGI approval for Molxvir® (Molnupiravir) in India

Press Release

Sun Pharma included in S&P Global Sustainability Yearbook 2024

The Sun Story

Watch the inspiring growth story of Sun – from humble beginnings in 1983 with just 2 employees and 5 psychiatry products to becoming the 4th largest global generic pharmaceutical company, selling over 2000 products in over 100 countries.

SunPharma on Twitter

Our Annual #GlobalHRMeet, CATALYST 2024 saw 100+ HR leaders from over 14 countries come together to chart out the strategy for the next year, over round table discussions, brainstorming sessions & team building activities!

#WeAreSun #SunPharma

In 2016, we introduced Gemcitabine InfuSMART, the first-ever ready-to-administer bag for oncology treatment. Developed in-house by our scientists, this innovation has since benefited numerous patients, making it a significant advancement in cancer care.

#40UnderTheSun #SunPharma

Sun Pharma has been included in the S&P Global Sustainability Yearbook 2024. This recognition underscores our unwavering commitment to embedding Environmental, Social, and Governance (ESG) principles across our diverse business operations.

Read more: https://bit.ly/3wdO5Yp

‘A made-in-India drug can be made available to the world at a lower cost. It will improve access to innovative medicines’ - Dilip Shanghvi
Our MD penned an article for @business_today, sharing what India must do to secure its rightful place in the global economy.

#WeAreSun

2

Join us for Sun Pharma Science Foundation’s 41st National Symposium on ‘Pathogen Discovery and Management of Future Epidemics’ and contribute towards shaping strategies for the management of future epidemics.
Register here: https://bit.ly/3Uukt2Y

#ReachingPeopleTouchingLives

Reflecting on a transformative moment in 2015, when Ranbaxy merged with Sun Pharma. This propelled us to become the 5th largest specialty generic pharma company globally and the No. 1 in India.

#40UnderTheSun #ReachingPeopleTouchingLives #WeAreSun #SunPharma

Our Managing Director, Dilip Shanghvi, penned an article for the @EconomicTimes on the interim Union Budget, where he shared his views on how he sees the budget steering India towards a future of comprehensive and sustainable growth.

Read it here: https://bit.ly/3SlBKZr

Our teams embrace the joy of being Great Place to Work® Certified™ in 25 countries. Together, we shine brightest!

#GPTWCertified #WeAreSun #TeamSunPharma

Load More

Find out more

Innovation

Science is at the heart of Sun Pharma. Our scientists work closely with doctors, patients, and business development teams, to generate innovative concepts and ideas to harness market needs and synergies across therapeutic areas.

Quality

Our vision is to globalize, harmonize and simplify GxP processes to achieve a sustainable quality culture.

Careers

We hire exceptionally talented individuals, and ensure they are nurtured professionally. Our multi-dimensional work environment offers high growth opportunities through challenging roles with clear responsibilities.

Responsibility

Our CSR efforts are focused on serving and helping needy and underprivileged communities. Our priority areas include: health, education, drinking water and sanitation.

Sun Pharma offers a program for individuals who want to disclose violations of US FDA requirements related to facilities or products owned or operated by Ranbaxy prior to Sun Pharma acquisition of Ranbaxy. Continue
Top